286 related articles for article (PubMed ID: 26826449)
1. Use of human stem cells in Huntington disease modeling and translational research.
Golas MM; Sander B
Exp Neurol; 2016 Apr; 278():76-90. PubMed ID: 26826449
[TBL] [Abstract][Full Text] [Related]
2. Human cellular models of medium spiny neuron development and Huntington disease.
Golas MM
Life Sci; 2018 Sep; 209():179-196. PubMed ID: 30031060
[TBL] [Abstract][Full Text] [Related]
3. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.
Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S
Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816
[TBL] [Abstract][Full Text] [Related]
4. Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.
Szlachcic WJ; Switonski PM; Krzyzosiak WJ; Figlerowicz M; Figiel M
Dis Model Mech; 2015 Sep; 8(9):1047-57. PubMed ID: 26092128
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
6. Multiple phenotypes in Huntington disease mouse neural stem cells.
Ritch JJ; Valencia A; Alexander J; Sapp E; Gatune L; Sangrey GR; Sinha S; Scherber CM; Zeitlin S; Sadri-Vakili G; Irimia D; Difiglia M; Kegel KB
Mol Cell Neurosci; 2012 May; 50(1):70-81. PubMed ID: 22508027
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
8. Advances in huntington disease drug discovery: novel approaches to model disease phenotypes.
Bard J; Wall MD; Lazari O; Arjomand J; Munoz-Sanjuan I
J Biomol Screen; 2014 Feb; 19(2):191-204. PubMed ID: 24196395
[TBL] [Abstract][Full Text] [Related]
9. Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death.
Conforti P; Camnasio S; Mutti C; Valenza M; Thompson M; Fossale E; Zeitlin S; MacDonald ME; Zuccato C; Cattaneo E
Neurobiol Dis; 2013 Feb; 50():160-70. PubMed ID: 23089356
[TBL] [Abstract][Full Text] [Related]
10. Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells.
Carter RL; Chen Y; Kunkanjanawan T; Xu Y; Moran SP; Putkhao K; Yang J; Huang AH; Parnpai R; Chan AW
Stem Cell Reports; 2014 Oct; 3(4):585-93. PubMed ID: 25358787
[TBL] [Abstract][Full Text] [Related]
11. Modeling Huntington׳s disease with patient-derived neurons.
Mattis VB; Svendsen CN
Brain Res; 2017 Feb; 1656():76-87. PubMed ID: 26459990
[TBL] [Abstract][Full Text] [Related]
12. Selective degeneration in YAC mouse models of Huntington disease.
Van Raamsdonk JM; Warby SC; Hayden MR
Brain Res Bull; 2007 Apr; 72(2-3):124-31. PubMed ID: 17352936
[TBL] [Abstract][Full Text] [Related]
13. Derivation of Huntington's disease-affected human embryonic stem cell lines.
Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
[TBL] [Abstract][Full Text] [Related]
14. Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblasts.
Kandasamy M; Rosskopf M; Wagner K; Klein B; Couillard-Despres S; Reitsamer HA; Stephan M; Nguyen HP; Riess O; Bogdahn U; Winkler J; von Hörsten S; Aigner L
PLoS One; 2015; 10(2):e0116069. PubMed ID: 25719447
[TBL] [Abstract][Full Text] [Related]
15. Stem cell transplantation for Huntington's diseases.
Choi KA; Choi Y; Hong S
Methods; 2018 Jan; 133():104-112. PubMed ID: 28867501
[TBL] [Abstract][Full Text] [Related]
16. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
Geater C; Hernandez S; Thompson L; Mattis VB
Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
[TBL] [Abstract][Full Text] [Related]
17. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.
Van Raamsdonk JM; Murphy Z; Slow EJ; Leavitt BR; Hayden MR
Hum Mol Genet; 2005 Dec; 14(24):3823-35. PubMed ID: 16278236
[TBL] [Abstract][Full Text] [Related]
18. Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.
Ring KL; An MC; Zhang N; O'Brien RN; Ramos EM; Gao F; Atwood R; Bailus BJ; Melov S; Mooney SD; Coppola G; Ellerby LM
Stem Cell Reports; 2015 Dec; 5(6):1023-1038. PubMed ID: 26651603
[TBL] [Abstract][Full Text] [Related]
19. A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration.
Lu B; Palacino J
FASEB J; 2013 May; 27(5):1820-9. PubMed ID: 23325320
[TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cell models of Huntington disease.
Niclis J; Trounson AO; Dottori M; Ellisdon A; Bottomley SP; Verlinsky Y; Cram D
Reprod Biomed Online; 2009 Jul; 19(1):106-13. PubMed ID: 19573298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
